Delivery Order SPE2DB25D3306-SPE2DB25FUCRV
- Not listed
- The Defense Logistics Agency awarded a $12,511.19 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Wezlana 90 mg/ml syringes on September 23, 2025, with completion scheduled for September 24, 2025. This competitive award, which includes no set-aside designation, represents a child delivery order issued under AmerisourceBergen's broader indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $47,074.22 delivery order to AmerisourceBergen Drug Corp for Wezlana 90 mg/ml syringes to be delivered to Conshohocken, Pennsylvania. The contract is competitively awarded with no set-aside designation and employs firm fixed-price pricing, with an ultimate completion date of June 24, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $33,849.19 delivery order for Wezlana 90 mg/ml syringes, with an ultimate completion date of August 4, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $13,626.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Wezlana 90 mg/ml syringes, with an ultimate completion date of September 3, 2025. This competitively awarded, non-set-aside contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical supply vehicle running through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order valued at $15,763.91 to AmerisourceBergen Drug Corp for Wezlana 90 mg/ml syringes, with a completion date of September 15, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The product will be delivered to the place of performance in Conshohocken, PA. This delivery order represents a task order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $82,826.37 to AmerisourceBergen Drug Corp for the supply of Wezlana 90 mg/ml syringes, with an ultimate completion date of September 9, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on September 8, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a $71,048.38 delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Wezlana 90 mg/mL syringes. The contract utilizes firm fixed pricing and carries an ultimate completion date of June 20, 2025. This competitively awarded delivery order was issued without a set-aside designation and will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $168,660.62 to AmerisourceBergen Drug Corp for the supply of Wezlana 90 mg/mL syringes. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,735.28 to AmerisourceBergen Drug Corp for Wezlana 90 mg/ml syringes. This firm fixed-price delivery order, issued on August 5, 2025, represents a non-competitive award executed under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 6,...
- The Defense Logistics Agency awarded a $33,133.71 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Wezlana 90 mg/ml syringes. This firm fixed price delivery order, with an ultimate completion date of September 15, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUCRVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $34,801.18 to AmerisourceBergen Drug Corp for the supply of Wezlana 90 mg/mL syringes, with an ultimate completion date of August 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through the DLA Medical Supply Chain. The company's contract portfolio demonstrates extensive capability in supplying pharmaceutical products and medical commodities across multiple therapeutic domains to support military and veteran healthcare systems. This delivery order for injectable pharmaceutical syringes is consistent with AmerisourceBergen's role as a primary pharmaceutical vendor supporting Defense Health Agency and broader military medical requirements through competitively awarded, firm fixed-price transactions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.8k | 8/21/25 |